Investments, Funding & Disinvestment

The latest investment represents the next phase in the long-term development of the Kemnath site, which plays a significant role in the company’s manufacturing operations.

The partnership brings together PureHealth’s expertise in healthcare and health longevity science with Aldar’s experience in developing integrated, people-centred master-planned communities.

Although Tanzania has not reported any confirmed Ebola cases, the government continues to enhance preparedness measures through its national contingency plans.

Khansaheb Investment LLC will transfer its 55 per cent stake, while Clemenceau Medical Company S.A.E.M.L. will sell its 25 per cent holding.

The multi-target collaboration will integrate Insilico’s proprietary Pharma.AI platform with Bora’s automated manufacturing and development capabilities to establish a next-generation model for drug innovation.

The assistance forms part of a wider U.S.-Madagascar health partnership established under the bilateral Global Health Memorandum of Understanding (MOU) signed in December 2025.

Samsung Biologics is pursuing the acquisition as demand for peptide therapeutics continues to accelerate, particularly amid the global success of GLP-1 medicines for treating obesity and type 2 diabetes.

The signing ceremony brought together National Treasury and Economic Planning Cabinet Secretary John Mbadi, U.S. Chargé d’Affaires Susan Burns, Health Cabinet Secretary Aden Duale, senior government officials and representatives from both countries.

The launch includes eight hospital-grade hemodialysis concentrate solutions designed to support the treatment of patients living with kidney failure.

The transaction, announced on July 3, includes Tanabe Pharma Factory’s production facilities in Onoda and Yoshitomi.